Regulating Blood Pressure During Recovery From Intracerebral Hemorrhage and Ischemic Stroke
A phase 2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 160 participants.
Also called NCT04760717
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 160 participants
- Registry
-
NCT04760717
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT04760717. Randomized; triple masking; primary purpose treatment. Start 2021-03-19 (actual); primary completion 2026-02-02 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Regulating Blood Pressure During Recovery From Intracerebral Hemorrhage and Ischemic Stroke
- Acronym
- REDUCE
- Condition
- Intracerebral Hemorrhage
- Condition
- Ischemic Stroke
- Condition
- Spironolactone
- Intervention (Drug)
- Spironolactone Pill
- Lead sponsor
- Yale University
- Collaborator
- American Heart Association
Record details
- Record id
cardio:ct-nct04760717- Content hash
c6cbf274df7382a86827092da9d0decca59a8849bda123c4bc40b5c13e2a9d16